A detailed history of Nilsine Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Nilsine Partners, LLC holds 13,184 shares of PFE stock, worth $365,196. This represents 0.05% of its overall portfolio holdings.

Number of Shares
13,184
Previous 13,204 0.15%
Holding current value
$365,196
Previous $380 Million 3.76%
% of portfolio
0.05%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$25.89 - $29.73 $517 - $594
-20 Reduced 0.15%
13,184 $366 Million
Q4 2023

Jan 24, 2024

SELL
$26.13 - $33.94 $14,789 - $19,210
-566 Reduced 4.11%
13,204 $380 Million
Q3 2023

Nov 01, 2023

SELL
$32.09 - $37.51 $31,608 - $36,947
-985 Reduced 6.68%
13,770 $457 Million
Q2 2023

Jul 21, 2023

SELL
$36.12 - $41.79 $109,407 - $126,581
-3,029 Reduced 17.03%
14,755 $541 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $700,511 - $911,963
17,784 New
17,784 $726 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $155B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Nilsine Partners, LLC Portfolio

Follow Nilsine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nilsine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nilsine Partners, LLC with notifications on news.